Homeβ€ΊSearchβ€ΊNature Reviews Drug Discovery

Nature Reviews Drug Discovery

Nature Research Β· United Kingdom Β· Est. 1967

ISSN1474-1784
SJR Q1βœ“ WOS SCIEβœ“ Scopus / SJR
96
/ 100
High Trust
PubScope credibility score from verifiable indexing & ethics signals
Score Breakdown
β—† WoS flagship (SCIE/SSCI/AHCI)78
βœ“ Corroboration (3 more)+18
Total96
Level data: Norwegian Register (HK-dir), NLOD 2.0. Β· Third-party records Β· how this is calculated Β· Report an error β†’
⚑ Speed vs Prestige
How does this journal balance review speed with impact level?
Publication speed: not measurable
publisher doesn’t disclose per-article submission dates β€” we never estimate
Q1
SJR Rank
Top 25% in field
Impact Factor & Quartile Β· Web of Science (JCR)

βœ“ Indexed in the Web of Science Core Collection (SCIE) β€” Clarivate publishes an official Journal Impact Factor and JCR quartile for this journal.

See the official Impact Factor & quartile on the journal’s page β†—

The Impact Factor & JCR quartile are licensed by Clarivate β€” we link you to the official source instead of reprinting a number that can go out of date. Open metrics below: SCImago Q1. Source: Clarivate Journal Citation Reports.

SJR Scorei
32.577
H-Indexi
470
CiteScore
ViewΒ β†—
Scopus metric Β· on the journal’s page
SNIPi
23.21
Total Worksi
6,795
Total Citationsi
763,811
2yr Mean Citednessi
11.90
Open Impact Factor alternative

Aims & Scope

Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.

General Information

Country / RegionUnited Kingdom
Primary LanguageEnglish
1st Year Published1967
FrequencyMonthly
StatusActive (last: 2026)
Total Publications6,795
Publisher OrgNature Portfolio
Visit Journal Website

Submission Info

Peer Reviewβ€”
Review Timeβ€”
Acceptance Rateβ€”
OA Licenseβ€”
OA Rateβ€”

Ethics & Quality

COPE Memberβœ— No
OASPA Memberβœ— No
Not on Predatory Listsβœ“ Yes
Plagiarism Detectionβœ“ Yes

Think.Check.Submit Compliance

7/12 Β· 58%
βœ…
Do you know the journal / publisher?
Nature Research
βœ…
Does the journal have a website?
βœ“ Linked
βœ…
Is the ISSN verified?
1474-1784
βœ…
Indexed in a trusted database?
WoS, Scopus
❌
Peer review process documented?
N/A
❌
Follows ethical publishing standards (COPE)?
N/A
❌
APC fees clearly disclosed?
N/A
βœ…
Not on predatory/blacklists?
βœ“ Clean
❌
Long-term digital preservation?
N/A
βœ…
Plagiarism detection in place?
Yes
❌
Listed in DOAJ (verified OA)?
N/A
βœ…
Primary language documented?
English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published
Citations received
242
34k
2019
251
34k
2020
247
35k
2021
243
20k
2022
244
10k
2023
244
5.9k
2024
241
2.2k
2025
135
67
2026

Source: OpenAlex Β· Each year’s green bar = citations earned by that year’s papers, counted to date β€” so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category β€” its quartile can differ by discipline.

Drug DiscoveryQ1
Medicine (miscellaneous)Q1
PharmacologyQ1

Subject Classification

Web of Science Categories

Biotechnology & Applied MicrobiologyPharmacology & Pharmacy

Scopus Categories

PharmacologyDrug DiscoveryMedicine (miscellaneous)

Research Topics (OpenAlex)

Science, Research, and MedicineBiotechnology and Related FieldsComputational Drug Discovery MethodsPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of LifeMonoclonal and Polyclonal Antibodies ResearchBiomedical Ethics and RegulationBiosimilars and Bioanalytical MethodsCAR-T cell therapy researchCRISPR and Genetic Engineering

Frequently asked questions about Nature Reviews Drug Discovery

Is Nature Reviews Drug Discovery a predatory journal?

PubScope has no integrity flags on record for Nature Reviews Drug Discovery: it is indexed in Web of Science, Scopus, and is not on DOAJ's withdrawn list. Its PubScope Trust Score is 96/100. Indexing is a transparency signal, not a guarantee β€” always confirm fit and policies before submitting.

What is the impact factor of Nature Reviews Drug Discovery?

Nature Reviews Drug Discovery is indexed in the Web of Science Core Collection, so Clarivate publishes an official Journal Impact Factor for it (since the 2023 Journal Citation Reports, every Core Collection journal β€” including Arts & Humanities and Emerging Sources titles β€” receives one). PubScope links to Clarivate's official source rather than reprinting the number, which can be out of date. Its open 2-year mean citedness is 11.90.

Is Nature Reviews Drug Discovery indexed in Scopus and Web of Science?

Nature Reviews Drug Discovery is indexed in Web of Science, Scopus.

What is the aims and scope of Nature Reviews Drug Discovery?

Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition to the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers, and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.

Compare This JournalFind Similar← Back to Search
Understand these signals
How to tell if a journal is predatoryWhat Q1–Q4 quartiles meanWeb of Science vs Scopus vs DOAJWhat is an APC?

Data updated: 2026-05-22 Β· Sources: SJR, DOAJ, OpenAlex, WoS, Crossref